NCT00932217

Study on the Incidence of Febrile Episodes During Stem Cells Collection After Chemotherapy in Patients With Multiple Myeloma

• Status: Unknown
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 180 (actual)
• Sponsor: University of Pisa · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the difference in the incidence of febrile episodes in patients undergoing stem cells mobilization with chemotherapy and filgrastim versus chemotherapy and lenograstim. A febrile episode will be considered as: body temperature \> 38°C for two measurements in the 24 hours with an interval of 6 hours at least between the two measurements.

Conditions

• G-CSF, Multiple Myeloma, Febrile Episode, Filgrastim, Leograstim

Interventions

Type	Name	Description
DRUG	filgrastim	subcutaneous filgrastim administration
DRUG	lenograstim	subcutaneous lenograstim administration

Timeline

• Start date: 2004-12-01
• Primary completion: 2007-04-01
• First posted: 2009-07-03
• Last updated: 2009-07-03